You are here

Metoklopramid Premedikasyonunun Vekuronyum ve Mivakuryum ile Sağlanan Nöromüsküler Blok Üzerindeki Etkisi

The Effects of Metoclopramide Premedication on the Neuromuscular Blockade of Vecuronium and Mivacurium

Journal Name:

Publication Year:

Abstract (2. Language): 
Elimination of metoclopramide is mostly made by cholinesterase enzyme. Especially cholinesterase enzyme took place at the cessation of the effects of depolarisating neuromuscular blocking agents. Cholinesterase enzyme levels can differentiate with metoclopramide administration. In this study we compared the effect of metoclopramide premedication with vecuronium and mivacurium's neuromuscular effects. Eighty patients undergoing elective general surgery operations were enrolled to the study. The patients were grouped according to the premedication of metoclopramide and to the neuromusculary blocking agent used as Group Metoclopramide-Mivacurium (n = 20), Group Mivacurium (n = 20), Group Metoclopramide-Vecuronium (n = 20), and Group Vecuronium (n = 20). The neuromuscular blockage was measured by accelomyography (TOF Guard), time to maximum blockage (sn), T25 (min.), T75 (min.), and recovery index (T25-T75) (min.) was enrolled. Student's t test, chi-square, repeated measures of ANOVA, posthoc Tukey-Kramer tests were used for statistical analysis. P < 0.05 values were accepted as statistically significant. There were no significant difference in on all data we studied. We suggest that neuromusculary functions of the patients medicated by metoclopramide and neuromusculary blocking agents should be monitorized during general anesthesia.
16-20

REFERENCES

References: 

1. Murphy E. J. A reappraisal of metoclopramide
Australian Medicines Handbook 2003: 79-88.
2. Motamed C, Kirov K, Combes X, et al. Effect of
metoclopramide on mivacurium-induced neuromuscular
block. Acta Anaesthesiol Scand 2002;
46: 214-216.
3. Scinner HJ,Girling KJ, Whitehurst A, Nathanson
MH. Influence of metoclopramide on plasma
cholinesterase and duration of action of mivacurium.
Br J Anaesth 1999; 82: 542-545.
4. Ostergaard D, Jensen FS, Jensen E, et al. Influence
of plasma cholinesterase activity on recovery from
mivacurium-induced neuromuscular blockade in
phenotypically normal patients. Acta Anaesthesiol
Scand 1992; 36: 702-706.
5. Ostergaard D, Jensen FS, Jensen E, et al. Mivacurium-
induced neuromuscular blockade in patients
with typical plasma cholinesterase. Acta Anaesthesiol
Scand 1993; 37: 314-318.
6 Naguib M, Daoud W, el Gammal M, et al. Enzymatic
antagonism of mivacurium-induced neuromuscular
blockade by human plasma cholinesterase.
Anesthesiology 1995; 83: 694-701.
7. Nava-Ocampo AA, Velazquez-Armenta Y, Moyao-
Garsia D, et al. Meta-analysis of the differences in
the time to onset of action between rocuronium
and vecuronium. Clin Exp Phamacol Physiol 2006;
33: 125-130.
8. Wierda JM, Hommes FD, Nap HJ, van den Broek
L. Time course of action and intubating conditions
following vecuronium, rocuroium and mivacurium.
Anaesthesia 1995; 50: 393-396

Thank you for copying data from http://www.arastirmax.com